1. Home
  2. TNGX vs EM Comparison

TNGX vs EM Comparison

Compare TNGX & EM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNGX
  • EM
  • Stock Information
  • Founded
  • TNGX 2014
  • EM 2017
  • Country
  • TNGX United States
  • EM China
  • Employees
  • TNGX N/A
  • EM N/A
  • Industry
  • TNGX Biotechnology: Pharmaceutical Preparations
  • EM Other Consumer Services
  • Sector
  • TNGX Health Care
  • EM Consumer Discretionary
  • Exchange
  • TNGX Nasdaq
  • EM Nasdaq
  • Market Cap
  • TNGX 317.4M
  • EM 297.2M
  • IPO Year
  • TNGX N/A
  • EM 2021
  • Fundamental
  • Price
  • TNGX $3.35
  • EM $1.15
  • Analyst Decision
  • TNGX Strong Buy
  • EM Strong Buy
  • Analyst Count
  • TNGX 8
  • EM 1
  • Target Price
  • TNGX $13.14
  • EM $1.00
  • AVG Volume (30 Days)
  • TNGX 757.1K
  • EM 1.9M
  • Earning Date
  • TNGX 03-17-2025
  • EM 03-27-2025
  • Dividend Yield
  • TNGX N/A
  • EM 2.29%
  • EPS Growth
  • TNGX N/A
  • EM N/A
  • EPS
  • TNGX N/A
  • EM 0.03
  • Revenue
  • TNGX $43,383,000.00
  • EM $269,745,696.00
  • Revenue This Year
  • TNGX $27.73
  • EM N/A
  • Revenue Next Year
  • TNGX N/A
  • EM $6.16
  • P/E Ratio
  • TNGX N/A
  • EM $35.64
  • Revenue Growth
  • TNGX 15.67
  • EM N/A
  • 52 Week Low
  • TNGX $2.59
  • EM $0.46
  • 52 Week High
  • TNGX $12.89
  • EM $1.18
  • Technical
  • Relative Strength Index (RSI)
  • TNGX 58.01
  • EM 81.97
  • Support Level
  • TNGX $2.82
  • EM $1.11
  • Resistance Level
  • TNGX $3.20
  • EM $1.17
  • Average True Range (ATR)
  • TNGX 0.20
  • EM 0.03
  • MACD
  • TNGX 0.05
  • EM -0.00
  • Stochastic Oscillator
  • TNGX 97.40
  • EM 91.89

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.

About EM Smart Share Global Limited

Smart Share Global Ltd is a consumer tech company providing mobile device charging service through an extensive online and offline network in China. It provides service through power banks, placed in POIs operated by location partners, such as entertainment venues, restaurants, shopping centers, hotels, transportation hubs, and public spaces. Through the mini-programs, users rent the power banks to carry with them when use the service and can return the power banks at any of the POIs, enabled by the expansive network and powerful technologies.

Share on Social Networks: